Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

The application period for the NHS Innovation Accelerator open from September 01, 2020

08 Sep 2020

The NHS Innovation Accelerator (NIA) has launched its call for applications representing high impact, evidence-based innovations from September 01, 2020.

NIA is an award-winning national initiative supported by England’s 15 Academic Health Science Networks (AHSNs), which helps dedicated innovations to spread more comprehensively in the healthcare system.

The applications can be submitted by passionate individuals from any background – clinicians, academics, a public-sector, charitable, or not-for-profit organization, from a small or medium-sized enterprise or a large corporate.

Innovations must address at least one of the following themes:

  • NHS response to COVID-19
  • Mental health
  • Supporting the NHS workforce

The innovation should demonstrate significant outcomes for significantly lower costs, be supported by an evidence-base, and ready to be diffused across the NHS.

The following documents provide full information on the process of completing and submitting the application:

Applications must be submitted via the application portal; the deadline is 23:59 October 16, 2020.

See more details here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.